Darren S. Cline - Jun 23, 2025 Form 3 Insider Report for Xenon Pharmaceuticals Inc. (XENE)

Role
Chief Commercial Officer
Signature
/s/ Nathaniel Adams, Attorney-in-fact
Stock symbol
XENE
Transactions as of
Jun 23, 2025
Transactions value $
$0
Form type
3
Date filed
6/24/2025, 09:33 PM
Previous filing
Jun 9, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Cline Darren S Chief Commercial Officer 3650 GILMORE WAY, BURNABY, BRITISH COLUMBIA, CANADA /s/ Nathaniel Adams, Attorney-in-fact 2025-06-25 0001633639

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding XENE No securities are beneficially owned. 0 Jun 23, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding XENE No securities are beneficially owned. Jun 23, 2025 N/A 0 $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Not applicable.